Engineered Pichia pastoris produces N-acetylneuraminic acid, suggesting a pathway for enhanced lactoferrin activity.
Free or protein-conjugated N-Acetylneuraminic acid (Neu5Ac) is widely distributed in organisms and possesses diverse biological functions, and for example lactoferrin with Neu5Ac-mediated sialylation exhibits significantly enhanced functional activity compared with non-sialylated lactoferrin. Pichia pastoris serves as an excellent host for lactoferrin; however, efficient biosynthesis of Neu5Ac is essential for efficiently expressing lactoferrin with Neu5Ac-mediated sialylation. In this study, P. pastoris was engineered into a high-yield Neu5Ac host for expressing highly active lactoferrin with Neu5Ac modification. Heterologous Neu5Ac biosynthesis genes (gfa1, gna1, yqaB, age, and neuB) were first introduced into a P. pastoris strain in which pfk1 and zwf attenuation combined with pfk2 deletion redirected carbon flux toward fructose-6-phosphate, yielding the Neu5Ac-producing strain P. pastoris N1 with Neu5Ac production of 9.19 mg/L. Neu5Ac titers were subsequently boosted 2.8-fold via precursor enhancement through pyk attenuation and gs overexpression. Implementation of glucose–glycerol co-utilization (gut1, gut2, gt2 overexpression) dramatically increased Neu5Ac production to 285.41 mg/L. Optimization via increased copy number of gfa1, age, and neuB, coupled with their overexpression under the strong promoter PGAP, culminated in approximately 111.5-fold improvement (reaching 1.03 g/L) over the N1 strain. The effective integration of diverse metabolic engineering strategies, including heterologous pathway introduction, precursor enhancement, and co-substrate utilization, established a valuable and transferable framework for reprogramming P. pastoris to synthesize Neu5Ac and other high-value compounds. • P. pastoris was engineered to synthesize Neu5Ac. • Neu5Ac production achieved 1.03 g/L via remodeling of key metabolic pathways. • The strain harbored potential for synthesis of free Neu5Ac or sialylated proteins.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: